information

Whoever comes in this website may find a hint

Phage therapy is influenced by:

Phage therapy is influenced by:

Country :
the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view

From Wikipedia


If the target host* of a phage therapy treatment is not
an animal the term "
biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

"In silico"

From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.

Saturday 23 August 2014

Mycobacterium ulcerans Agy99, complete genome


Chromosomes: genome
Plasmids: pMUM001

Genome Info:Features:BLAST homologs:Links:Review Info:
Refseq: NC_008611 Genes: 4981COGGenome ProjectPublications: [1]
GenBank: CP000325Protein coding: 4160TaxMapRefseq FTPRefseq Status: PROVISIONAL
Length: 5,631,606 ntStructural RNAs: 50TaxPlotGenBank FTPSeq.Status: Completed
GC Content: 65% Pseudo genes: 771GenePlotBLASTSequencing center: Institut Pasteur
% Coding: 
 72%
Others: 452gMapTraceAssembly Completed: 2006/12/04
Topology: circularContigs: None
CDDOrganism Group
Molecule: DNA

Other genomes for species:

Gene Classification based on COG functional categories